Nutex Health Inc. (NUTX)
| Market Cap | 801.99M |
| Revenue (ttm) | 875.26M |
| Net Income (ttm) | 70.79M |
| Shares Out | 6.97M |
| EPS (ttm) | 10.48 |
| PE Ratio | 10.98 |
| Forward PE | 6.17 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 194,230 |
| Open | 108.98 |
| Previous Close | 110.79 |
| Day's Range | 107.45 - 115.87 |
| 52-Week Range | 77.21 - 193.07 |
| Beta | 2.03 |
| Analysts | Strong Buy |
| Price Target | 252.50 (+119.39%) |
| Earnings Date | Apr 30, 2026 |
About NUTX
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatie... [Read more]
Financial Performance
In 2025, Nutex Health's revenue was $875.26 million, an increase of 82.36% compared to the previous year's $479.95 million. Earnings were $70.79 million, an increase of 35.88%.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for NUTX stock is "Strong Buy." The 12-month stock price target is $252.5, which is an increase of 119.39% from the latest price.
News
Nutex Health Transcript: AGM 2026
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by the required majority. Voting results will be reported on Form 8-K within four business days.
Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatie...
Nutex Health Earnings Call Transcript: Q4 2025
Revenue grew 82% to $875.3M in 2025, with net income up to $70.8M and adjusted EBITDA rising 152.6%. Despite a one-time $55M arbitration true-up in Q4, cash flow and patient volumes remained strong, supporting expansion and capital returns.
Nutex Health Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation
Block & Leviton is investigating Nutex Health, Inc. (Nasdaq: NUTX) for potential securities fraud. Investors should contact the firm to recover losses.
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
FULL YEAR 2025 HIGHLIGHTS: Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an increase of 82.4% Net income attributable to Nutex Health of $70.8 million for ...
Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call
HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatien...
NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON
HOUSTON, Jan. 12, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro...
NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro ...
NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS
HOUSTON , Dec. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micr...
NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES , Dec. 11, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nutex Health Inc. ("...
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN
HOUSTON , Dec. 4, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 25 state-of-the-art micro...
Nutex Health Earnings Call Transcript: Q3 2025
Q2 and Q3 2025 saw record revenue and profitability, driven by hospital division growth, improved margins, and strong cash flow. Expansion continues with new hospitals and IPA growth, while reliance on the IDR process and payer negotiations remain key factors.
NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT
HOUSTON , Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November 25, 2025 by Capybara Research. Based on...
NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS
HOUSTON , Nov. 24, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 25 state-of-the-art micr...
NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5% Net income attributable to Nutex Health Inc. of $59.0 m...
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 217.5% Net income attributable to Nutex Health Inc. of $3.5 million for th...
NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 mi...
NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS
FULL YEAR 2024 HIGHLIGHTS: Total revenue of $479.9 million for the year 2024 versus $247.6 million for the year 2023, an increase of 93.8% Net income attributable to Nutex Health Inc. of $52.1 million...
NUTEX HEALTH PROVIDES CORPORATE UPDATE
Significant Year-over-Year Growth in Patient Volume and Cash Collections HOUSTON , Oct. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, in...
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
NUTX Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 21st Deadline SAN FRANCISCO , Oct. 17, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of m...
NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Health Investors to Contact the Firm Before the October 21st Deadline
The complaint alleges Nutex misled investors by concealing fraudulent HaloMD arbitration practices, weak controls, and misstated stock-based liabilities.
NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired s...
NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Investors to Contact the Firm Before the October 21st Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired ...
Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
HOUSTON , Oct. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro...